LAURUSLABS:NSE
Laurus Labs Ltd
₹ २,०६९.००
arrow_upward
+०.४३%(+८.९०) 1D
अक्टोबर १९, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LAURUSLABS...
Open
₹ २,०६०.१०
High
₹ २,०८९.००
Low
₹ २,०५२.२०
Mkt. cap
११.१२ खरब
Avg. vol.
१५.९८ लाख
Volume
११.३३ लाख
Dividend
०.१०%
Quarterly dividend
₹ ०.५०
Ex-dividend date
२०२६ मे ८
P/E ratio
१०२.३०
52-wk high
₹ २,०८९.००
52-wk low
₹ ९०१.४०
EPS
₹ २०.२३
Shares outstanding
१०.६४ करोड
No. of employees
७ हजार
Open
₹ २,०६०.१०
High
₹ २,०८९.००
Low
₹ २,०५२.२०
Mkt. cap
११.१२ खरब
Avg. vol.
१५.९८ लाख
Volume
११.३३ लाख
Dividend
०.१०%
Quarterly dividend
₹ ०.५०
Ex-dividend date
२०२६ मे ८
P/E ratio
१०२.३०
52-wk high
₹ २,०८९.००
52-wk low
₹ ९०१.४०
EPS
₹ २०.२३
Shares outstanding
१०.६४ करोड
No. of employees
७ हजार
News stories
From web sources and news partners
Simply Wall Street
·
१ घण्टा पहिले
Why Is Recursion Pharmaceuticals (RXRX) Drawing Attention After AI Drug And Trial Milestones?
qz.com
·
१ घण्टा पहिले
Eric Criscuolo on the Dow Jones climbing the wall of worry
MarketBeat
·
१४ मिनेट पहिले
Neutron (NASDAQ:LIME) Stock Falls 4.9% - Time to Sell?
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd